CLL Support Association
9,254 members14,627 posts

Acalabrutinib Safe, Effective in Ibrutinib-Intolerant CLL/SLL

“Based on these preliminary findings, we feel that acalabrutinib has promising activity in this group of patients, and safety, and it’s effective very quickly and it appears at least in the early follow-up to have durability,” said Awan, associate professor, division of hematology, department of internal medicine, Ohio State University.

onclive.com/conference-cove...

Jeff

3 Replies
oldestnewest

Thanks for posting these!!!

Reply

I love repeating great news!👍🏻🎉🍻

1 like
Reply

Anxious to hear more on Acalabrutinib in Complex Karyotype with unmutated and Notch1 in frontline.

Reply

You may also like...